96 results
8-K
EX-99.1
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
, the parent mAb of pemivibart, and other mAbs that were previously authorized for EUA. There are limitations of the data supporting the benefits of PEMGARDA … statements concerning, among other things, the anticipated benefits of the company’s management transition; the company’s anticipated next phase
8-K
EX-10.1
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
trigger for the Company’s payment of any severance benefits to Executive pursuant to the Executive Agreement. The Company and Executive further agree
8-K
EX-99.1
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
of pemivibart, and other mAbs that were previously authorized for EUA. There are limitations of the data supporting the benefits of PEMGARDA. Evidence
8-K
EX-99.1
tjk71q7
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
EX-99.1
5h6u p01va73md4e
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.3
dlj8 4brij
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
bk4jkm313zo85c5k7d
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-10.1
mtkfzc7
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
9rtgay o8irwz
22 Dec 23
Prospectus supplement for primary offering
4:51pm